Skip to content
← Full study record

NCT00970502 · MORE INFO

Limitations, agreements, and source contact

Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer · Source last updated 2017-04-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
johnnykaomd@gmail.com
organization
Florida Radiation Oncology Group
phone
813-661-6442
title
Dr. Johnny Kao
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
johnnykaomd@gmail.com
organization
Florida Radiation Oncology Group
phone
813-661-6442
title
Dr. Johnny Kao

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice